10X Genomics, Inc. (TXG)
93.50
+4.74
(+5.34%)
USD |
NASDAQ |
Oct 02, 16:00
94.00
+0.50
(+0.53%)
After-Hours: 20:00
10X Genomics Enterprise Value : 11.71B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 11.71B |
| October 01, 2026 | 11.09B |
| September 30, 2026 | 11.30B |
| September 29, 2026 | 11.26B |
| September 28, 2026 | 11.06B |
| September 25, 2026 | 10.69B |
| September 24, 2026 | 10.48B |
| September 23, 2026 | 9.379B |
| September 22, 2026 | 10.04B |
| September 21, 2026 | 9.832B |
| September 18, 2026 | 9.506B |
| September 17, 2026 | 9.555B |
| September 16, 2026 | 8.996B |
| September 15, 2026 | 9.218B |
| September 14, 2026 | 8.661B |
| September 11, 2026 | 8.463B |
| September 10, 2026 | 8.175B |
| September 09, 2026 | 8.293B |
| September 08, 2026 | 8.073B |
| September 04, 2026 | 7.689B |
| September 03, 2026 | 7.763B |
| September 02, 2026 | 7.559B |
| September 01, 2026 | 7.341B |
| August 31, 2026 | 7.663B |
| August 28, 2026 | 7.544B |
| Date | Value |
|---|---|
| August 27, 2026 | 7.976B |
| August 26, 2026 | 7.899B |
| August 25, 2026 | 7.959B |
| August 24, 2026 | 7.839B |
| August 21, 2026 | 8.011B |
| August 20, 2026 | 7.848B |
| August 19, 2026 | 7.629B |
| August 18, 2026 | 6.774B |
| August 17, 2026 | 7.082B |
| August 14, 2026 | 6.834B |
| August 13, 2026 | 7.103B |
| August 12, 2026 | 7.051B |
| August 11, 2026 | 7.146B |
| August 10, 2026 | 7.157B |
| August 07, 2026 | 6.305B |
| August 06, 2026 | 5.468B |
| August 05, 2026 | 5.710B |
| August 04, 2026 | 5.762B |
| August 03, 2026 | 5.651B |
| July 31, 2026 | 5.685B |
| July 30, 2026 | 5.967B |
| July 29, 2026 | 5.561B |
| July 28, 2026 | 5.657B |
| July 27, 2026 | 5.509B |
| July 24, 2026 | 5.555B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 11.75B |
| Tempus AI, Inc. | 14.43B |
| Personalis, Inc. | 1.557B |
| Alamar Biosciences, Inc. (California) | 2.186B |
| Beam Therapeutics, Inc. | 1.624B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.93M |
| Revenue (Quarterly) | 151.04M |
| Total Expenses (Quarterly) | 168.97M |
| EPS Diluted (Quarterly) | -0.138 |
| Gross Profit Margin (Quarterly) | 74.36% |
| Profit Margin (Quarterly) | -11.87% |
| Earnings Yield | -0.63% |
| Normalized Earnings Yield | -0.6433 |